Blog - 1-800-PublicRelations, Inc. (1800pr) PR Agency

15 Apr

UPDATE: CEO Corrado De Gasperis of Comstock Mining Inc. to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW 1190AM

Interview at 1:00 pm CST / 2:00 pm EST on The Traders Network Radio Show, Hosted by Michael Yorba

VIRGINIA CITY, NV–(Feb 4, 2014) – Comstock Mining Inc. (the “Company”) (NYSE MKT: LODE), a Nevada-based producing gold and silver company, today announced that its CEO Corrado De Gasperis will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network. All investors, analysts, industry professionals and prospective customers that are interested to learn more about Comstock Mining, its goals and recent developments are invited to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Tuesday, February 4, 2014
Start Time: 1:00 pm CST | 11:00 am PST | 2:00 pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM Dallas-Ft. Worth
Live Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Host: Michael Yorba

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country reaching more than 112 million listeners.www.clearchannel.com.

About Michael Yorba: Mr. Yorba is a featured host on Clear Channel’s DFW 1190AM in Dallas-Ft. Worth, TX. For the past six years he has been integrally involved with the media industry, including building an IPTV Network, developing, producing and hosting a daily one-hour talk show called Commodity Classics, and then The Traders Network, an audience empowered interactive financial program that has been broadcast live on radio, television and the Internet.

About Comstock Mining Inc.

Comstock Mining Inc. is a producing, Nevada-based, gold and silver mining company with extensive, contiguous property in the Comstock District. The Company began acquiring properties in the Comstock District in 2003. Since then, the Company has consolidated a significant portion of the Comstock District, amassed the single largest known repository of historical and current geological data on the Comstock region, secured permits, built an infrastructure and commenced production in 2012. The Company continues acquiring additional properties in the district, expanding its footprint and creating opportunities for further exploration and mining. The near term goal of our business plan is to deliver stockholder value by validating qualified resources (measured and indicated) and reserves (proven and probable) of at least 3,250,000 gold equivalent ounces from our first two resource areas, Lucerne and Dayton, achieve initial commercial mining and processing operations in the Lucerne Mine with annual production rates of approximately 40,000 gold equivalent ounces and significantly grow production through the commercial development and expansions of both the Lucerne and Dayton Mine plans.

Forward-Looking Statements

This press release and any related calls or discussions may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Comstock. Forward-looking statements are statements that are not historical facts. All statements, other than statements of historical facts, are forward-looking statements. Forward-looking statements include statements about matters such as: future prices and sales of, and demand for, our products; future industry market conditions; future changes in our exploration activities, production capacity and operations; future exploration, production, operating and overhead costs; operational and management restructuring activities (including implementation of methodologies and changes in the board of directors); future employment and contributions of personnel; tax and interest rates; capital expenditures and their impact on us; nature and timing and accounting for restructuring charges, gains or losses on debt extinguishment, derivative liabilities and the impact thereof; productivity, business process, rationalization, investment, acquisition, consulting, operational, tax, financial and capital projects and initiatives; contingencies; environmental compliance and changes in the regulatory environment; offerings, sales and other actions regarding debt or equity securities; and future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, earnings and growth.

The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors discussed in Item 1A, “Risk Factors” of our annual report on Form 10-K and the following: current global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, including risks of diminishing quantities or grades of qualified resources and reserves; operational or technical difficulties in connection with exploration or mining activities; contests over our title to properties; potential dilution to our stockholders from the conversion of securities that are convertible into or exercisable for shares of our common stock; potential inability to continue to comply with government regulations; adoption of or changes in legislation or regulations adversely affecting our businesses; business opportunities that may be presented to, or pursued by, us; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to unexpected equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, copper, diesel fuel, and electricity); changes in generally accepted accounting principles; geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues organically; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies and equipment raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the SEC; potential inability to maintain the listing of our securities on any securities exchange or market; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. We undertake no obligation to publicly update or revise any forward-looking statement.

Neither this press release nor any related calls or discussions constitute an offer to sell or the solicitation of an offer to buy any securities.

A www.1800PublicRelations.com PR Event…

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Comstock Mining Inc., Corrado De Gasperis, Gold, LODE, Mining, Public Relations, Silver Comments Off Read more...

15 Apr

CEO Corrado De Gasperis of Comstock Mining Inc. to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW 1190AM

Interview at 1:00 pm CST / 2:00 pm EST on The Traders Network Radio Show, Hosted by Michael Yorba

VIRGINIA CITY, NV–(Feb 3, 2014) – Comstock Mining Inc. (the “Company”) (NYSE MKT: LODE), a Nevada-based producing gold and silver company, today announced that its CEO Corrado De Gasperis will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network. All investors, analysts, industry professionals and prospective customers that are interested to learn more about Comstock Mining, its goals and recent developments are invited to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Monday, February 3, 2014
Start Time: 1:00 pm CST | 11:00 am PST | 2:00 pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM Dallas-Ft. Worth
Live Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Host: Michael Yorba

About Comstock Mining Inc.

Forward-Looking Statements

Neither this press release nor any related calls or discussions constitute an offer to sell or the solicitation of an offer to buy any securities.

A www.1800PublicRelations.com PR Event…

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Comstock Mining Inc., Corrado De Gasperis, Gold, LODE, Mining, Public Relations, Silver Comments Off Read more...

15 Apr

Bill Solms, CEO of Security Software Provider Wave Systems, to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW1190AM

Interview at 2:15 pm CST / 3:15 pm EST on The Traders Network Radio Show, Hosted by Michael Yorba

DALLAS, TX and LEE, MA–(Jan 23, 2014) – Wave Systems Corp. (NASDAQ:WAVX), a provider of security software solutions for endpoint devices, announced that its CEO Bill Solms will interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network. All investors, analysts, industry professionals and prospective customers that are interested to learn more about Wave Systems, its goals and recent developments are invited to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Thursday, January 23, 2014
Start Time: 2:15pm CST | 12:15pm PST | 3:15pm EST (U.S.)
Network:  Clear Channel
Station:  DFW 1190AM Dallas-Ft. Worth
Live Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Host:  Michael Yorba

About Wave Systems
Wave Systems provides security software that leverages industry standard hardware to provide more robust data and network protection for endpoint computing devices including PCs, laptops and tablets. Wave helped to pioneer this “Ultra-Secure” paradigm for devices and to shape industry standards for enabling hardware. Wave’s approach gives organizations, especially in security-sensitive sectors such as health care, government, finance, and higher education, unprecedented control over data protection and network access, no matter the device or network. Wave simple, cost-effective solutions deliver protection against ever-more sophisticated cyber threats along with management for a growing array of devices and compliance issues. www.wave.com

Safe Harbor for Forward-Looking Statements
Mr. Solms’ interview comments may contain forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company or its officers with respect to, among other things: (i) the company’s growth strategy & operating plans; (ii) industry trends, customer spending priorities and competitive issues within the IT security marketplace; and (iii) issues affecting the company’s financial condition, fund raising efforts or results of operations. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions or concepts are intended to identify forward-looking statements in Mr. Solms’ remarks. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and as a result of various factors, actual results may differ materially from those projected in the forward-looking statements. Wave assumes no duty to and does not undertake to update any forward-looking statements.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Bill Solms, Public Relations, Security Software Provider Wave Systems, Wave Systems Corp, WAVX Comments Off Read more...

15 Apr

Vycor Medical, Inc. President David Cantor to Be Interviewed Today on Clear Channel Business Talk Radio DFW1190AM

Mr. Cantor to Be Interviewed Live Today at 2:00 pm CST / 3:00 pm EST on The Traders Network Radio Show by Host Michael Yorba

BOCA RATON, FL–(Jan 23, 2014) – Vycor Medical, Inc. (“Vycor”) (OTCBB:VYCO), a medical device company with a suite of FDA cleared products, announced today that President David Cantor will interviewed live by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network.

The interview will air today Thursday, January 23, 2014, at 2:00pm U.S. Central Standard Time / 12:00pm Pacific Standard Time / 3:00pm Eastern Standard Time at DFW1190AM and broadcasted nationally via iHeart Radio.

We encourage all investors, institutional analysts, industry professionals, customers and others who are interested in learning more about Vycor Medical’s NovaVision recent developments to tune in and listen live via Clear Channel’s iHeart Radio stream. Details below.

Live Interview via iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Date: January 23, 2014
Time: 2:00pm CST | 12:00pm PST | 3:00pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country. DFW1190AM.com Dallas-Ft. Worth.www.clearchannel.com.

About Michael Yorba: Michael Yorba is the featured host of Clear Channels DFW 1190AM in Dallas-Ft. Worth, TX. For the past six years he has been integrally involved with the media industry in various capacities including building an IPTV Network, developing, producing and hosting a daily one hour talk show called Commodity Classics, and then later The Traders Network, defined as an audience empowered interactive financial program that has been broadcast live on Internet, television and radio. His focus has been on derivative portfolio analysis for individual and corporate clients through the use of futures and futures options, managed funds, and Forex. www.yorbamedia.com.

About Vycor Medical, Inc.

Vycor Medical, Inc. (“Vycor”) is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA-cleared medical solutions that are changing and improving lives every day. The Company operates two wholly-owned business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Both technologies have exceptional sales growth potential, address large potential markets, have the requisite regulatory approvals and are commercialized and generating revenue.

Vycor Medical’s flagship, ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices that hold the potential for speedier, safer and more economical brain surgeries and a quicker patient discharge. VBAS is designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the professional medical community. Vycor Medical is ISO 13485:2003 compliant, has FDA 510(K) clearance for VBAS for brain and spine surgeries and regulatory approvals for brain surgeries in Australia, Canada, China, Europe, Japan, Korea and Russia. For an overview of Vycor Medical’s VBAS see http://player.vimeo.com/video/39766887

NovaVision develops and provides science-driven neurostimulation therapy and other medical technologies that help improve and partially restore sight in patients with neurological vision impairments. The company’s proprietary Visual Restoration Therapy® (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury (“TBI”), or other acquired brain injuries. VRT is the only FDA 510K cleared medical device in the U.S. aimed at the restoration of vision for neurologically induced vision loss and can be prescribed by any ophthalmologist, optometrist, neurologist or physiatrist. VRT also has CE Marking for the EU. NovaVision also recently launched NeuroEyeCoach™, a new Internet-based “direct to the patient” saccadic eye training program. The Company also provides Neuro-Eye Therapy (NeET) in the EU, aimed at increasing visual sensitivity deep within the field defect. For an overview of NovaVision see:
http://player.vimeo.com/video/39765566

For the latest information on the company, including media and other coverage, and to learn more, please go online at www.vycormedical.com or www.novavision.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Brain Surgery, David Cantor, Public Relations, Spine Surgery, VYCO, Vycor Medical Inc. Comments Off Read more...

15 Apr

Vycor’s NovaVision Unit Announces the Commercial Release of NeuroEyeCoach™ — A Novel Saccadic Eye Training Therapy

NeuroEyeCoach™ Vision Therapy Is Available Direct to Patients via the Internet

BOCA RATON, FL–(Jan 23, 2014) – Vycor Medical, Inc. (“Vycor”) (OTCBB:VYCO), a medical device company with a suite of FDA cleared products, announced today that its wholly-owned subsidiary, NovaVision has launched the first commercial release of its new saccadic eye training therapy which will be marketed in the U.S. as NeuroEyeCoach™. The therapy is now available through the web sitewww.NeuroEyeCoach.com.

To carry out normal daily tasks, such as finding an object at home or on a supermarket shelf, one needs to make effective eye movements. Unfortunately, normal eye movements are also affected after brain injury making it difficult to integrate visual information and adding to the problems of blindness. Training is needed for patients to learn to make effective use of their eye movement again. NeuroEyeCoach™ has been specifically developed with world-renowned professors in the field to increase the efficiency of eye movement and train the patient to make the most of their remaining vision.

NeuroEyeCoach™ addresses an enormous worldwide market that currently is largely not addressed. It is estimated that in the U.S. alone, there are over 8 million Americans who have suffered a stroke and there are more than 700,000 new stroke cases occurring annually. About 30% of patients with acquired brain injury suffer from visual disorders with stroke being the most frequent cause.

NeuroEyeCoach™ is an innovative program which evolved from Professor Zihl’s (a NovaVision Scientific Advisor) extensive research and pioneering of a computer-based saccadic treatment approach which has been the subject of numerous studies. NeuroEyeCoach™ distills all of Professor Zihl’s clinical findings into one comprehensive therapeutic product for improving a patient’s ability to scan their environment more efficiently.

NeuroEyeCoach™ is the first commercially available saccadic eye training therapy offered via the Internet direct to patients at home. The program is designed to:

Provide meaningful improvement in visual search performance resulting in improvements in navigation skills and object finding.
Increase the efficiency of a patient’s eye movement and re-train the patient’s ability to make most of their remaining vision
Be carried out in comfort at home on patient’s computer; the program is intuitive and user friendly and has been designed not to be overly taxing and can be completed in 2-4 weeks
Have a real positive impact on activities of daily living.

At www.NeuroEyeCoach.com, information can be found on the therapy and patients can register and download the program. The therapy is delivered over the Internet, allowing for the patient to complete the training in the comfort of their home. NeuroEyeCoach™ can also be provided as a clinic-based multi-user device. The device will enable healthcare professionals to provide the therapy to patients under supervision. Alternatively, clinics can use the device to enable patients to try out the therapy while in the clinic. Patients can then be referred to NovaVision for completion of the NeuroEyeCoach™ therapy at home.

Commenting on the announcement, David Cantor, President of Vycor, stated, “We believe today’s launch of NeuroEyeCoach™ is a game changer for Vycor. The therapy addresses a very substantial and under-served market. NeuroEyeCoach™ has been designed and developed to meaningfully improve a patient’s ability to scan their environment, resulting in a very positive impact on their ability to deal with every day living. We believe there are literally millions of people worldwide who could benefit from this therapy.”

Vycor’s wholly-owned NovaVision subsidiary is the worldwide leader in the field of neurologically-induced vision loss. In addition to NeuroEyeCoach™, NovaVision markets a non-invasive, computer-based light stimulation therapy called Vision Restoration Therapy (VRT™), which is the only medical device aimed at the restoration of vision for neurologically induced vision loss which has FDA 510 (K) clearance to be marketed in the U.S.

The NeuroEyeCoach™ therapy is highly complementary to VRT™. The two therapies address different visual disabilities each of which results from neurological damage-induced vision loss — a loss of visual field as well as difficulty with eye movement, affecting the ability to integrate visual information. VRT provides partial restoration of the patient’s lost visual field. NeuroEyeCoach™ has been specifically developed to increase the efficiency of eye movement and re-train the patients’ ability to integrate visual information between the left and right hand side.

The Company is in parallel actively working on re-engineering its VRT to also enable it for direct to the patient Internet delivery and to streamline a number of business processes related to the delivery and servicing of patients, although the therapy itself will remain unchanged. Once completed, NovaVision plans to offer both NeuroEyeCoach™ and VRT alongside each other in one therapy suite creating the most robust, affordable, Internet-based visual therapy solution targeted at neurologically induced vision loss.

NeuroEyeCoach™ is a result of collaboration between Vycor management, its Chief Scientific Officer Prof. Arash Sahraie, (Chair in Vision Sciences, College of Life Sciences and Medicine at the University of Aberdeen) and Josef Zihl and the rest of its world class NovaVision Scientific Advisory Board.

About Vycor Medical, Inc.
Vycor Medical, Inc. (“Vycor”) is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA-cleared medical solutions that are changing and improving lives every day. The Company operates two wholly-owned business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Both technologies have exceptional sales growth potential, address large potential markets, have the requisite regulatory approvals and are commercialized and generating revenue.

For the latest information on the company, including media and other coverage, and to learn more, please go online at www.vycormedical.com or www.novavision.com.

Safe Harbor Statement

Brought to you by www.1800PublicRelations.com

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Eye Training Therapy, NeuroEyeCoach, Public Relations, Vision Therapy, VYCO, Vycor Medical Inc. Comments Off Read more...

15 Apr

Gate Global Impact CEO Vince Molinari to Be Interviewed Today on Clear Channel Business Talk Radio DFW1190AM

Mr. Molinari to Be Interviewed Live Today at 2:00 pm CST / 3:00 pm EST on The Traders Network Radio Show by Host Michael Yorba

NEW YORK, NY–(Jan 16, 2014) – Gate Global Impact, Inc. is an Impact Investing-focused electronic regulatory compliant marketplace that provides market infrastructure and related services for the emerging Impact Investment industry. Today announced CEO Vince Molinari will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network.

The interview will air today Thursday, January 16, 2014, at 2:00pm U.S. Central Standard Time / 12:00pm Pacific Standard Time / 3:00pm Eastern Standard Time at DFW1190AM.

We encourage all investors, institutional analysts, industry professionals, customers and others who are interested in learning more about recent crowd-funding and impact-investing market trends to tune in and listen live via Clear Channel’s iHeart Radio stream. Details below.

Live Interview via iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Date: January 16, 2014
Time: 2:00pm CST | 12:00pm PST | 3:00pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country. DFW1190AM.com Dallas-Ft. Worth. www.clearchannel.com.

About Gate Global Impact: GATE Global Impact INC is an Impact Investing-focused electronic regulatory compliant marketplace that provides market infrastructure and related services for the emerging Impact Investment industry — public and private investments with a sustainable social and/or environmental component that also may generate a rate of financial return. www.gateglobalimpact.com

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Ceo, Gate Global Impact, Impact Investing, Investments, Public Relations, Vince Molinari Comments Off Read more...

15 Apr

CES Wrap-Up: UV Flu Technologies and Vystar Corp.’s “Perfect Sleep Environment” Attracts Global Interest

CHICAGO, IL and ATLANTA, GA–(Jan 14, 2014) –

New Microbe/Germ-Killing Air Purifier
Eco-Friendly Hypo-Allergenic Natural Rubber Latex Foam Pillow and Bedding/Cushion Material

For the first time, UV Flu Technologies (OTCBB: UVFT) and Vystar Corporation’s (OTCBB:VYST) shared an international stage with the world’s most innovative companies at theConsumer Electronics Show (CES) as the two companies showcased “The Perfect Sleep Environment” with Vystar’s Vytex® Natural Rubber Latex (NRL) pillow and UVFT’s UV-based, microbe-, spore- and germ-killing air purification system. The technologies attracted the attention of numerous new manufacturers and suppliers that have been actively seeking these solutions. Vystar and UVFT are now further exploring multiple business opportunities worldwide and have moved closer to finalizing multi-million dollar contracts with potential partners, manufacturers, suppliers and distributors.

“The global business contacts and opportunities generated at CES for both of our companies were excellent and far exceeded any previous efforts,” stated Michael Ross, UVFT CEO. “We look forward to sharing details as contracts are finalized.”

Life-changing Air Purification Technology

UV Flu’s UV300®, which will be available to consumers by yearend 2014, will change lives by providing relief for sufferers of chronic respiratory inflammation, infections, asthma and allergies due to airborne sources. The prototype, known currently as UV-300, features new ultra-fine particulate matter filters, plus sensors and electronics that UVFT is still keeping under wraps, in addition to containing the only pure UV-based, FDA-cleared, class II medical device technology used in UVFT’s RXAir™ purification systems designed for hospitals and medical facilities. Unlike other air purification systems that simply circulate air over trapped particulate matter and recirculate the microbes, spores in the outflow, UVFT’s patented ViraTech™ UV technology kills organic matter entering the purifier chamber and traps it, as well as trapping inorganic matter. The result is totally pure, hygienic fresh air to help maintain a healthy environment.

“The UV300 will have significant benefits for asthma and allergy sufferers and those subject to environments high in particulate matter,” explained Ross. “In addition to utilizing ultraviolet (UV) light, which kills more than 99% of airborne bacteria and viruses with every pass, the new UV-300 traps minute pollen, fungi, spores and other airborne particulate matter and reduces odors from smoke, pets and volatile organic compounds (VOCs) that often cause irritation, inflammation and/or immune system reactions.”

Perfect Sleep Environment for Better Health

Everyone deserves a good night’s sleep. UVFT and Vystar, owner of Vytex NRL a multi-patented, all-natural raw material that contains significantly reduced levels of non-rubber particles and proteins found in natural rubber latex, are making sure you will sleep better and rest more comfortably by providing the ideal sleep environment from the air you breathe to the pillow you rest on.

Vystar’s SleepHealth™ pillow’s tight cell structure conforms to body contours, yet allows greater air flow to avoid heat and moisture build up, resist mildew, odors and dust mites while maintaining its resilience and durability over time. The all natural NRL foam employs patented processes to remove the non-rubber particles and allergen-causing latex proteins to create a superior eco-friendly, hypo-allergenic product that is whiter, lighter weight and free of the off-gassing common among competitors’ memory foam products. Vystar’s foam manufacturing partners, Guatemalan-based Islatex and GrupoAgroindustrialOccidente, developed a unique foam manufacturing process that provides consumers with products that have the most desirable attributes, such as superior longevity, temperature and humidity regulation, ventilation, allergy-friendly, non-toxic, and luxurious comfort.

“Many people, even those without diagnosed allergies, wake up in the morning with congestion, often as a result of exposure to irritants and allergens in both the air and their non-Vytex based bedding products, yet have noted that this congestion does not occur in test trials using our foam products while also remaining cooler though the night,” noted Vystar CEO William Doyle. “The perfect sleep environment created with UVFT’s air purification system and our Vytex NRL foam pillows will be further enhanced with the Vytex mattress products that we expect to launch in the coming months. Rather than fighting off germs, allergens and other irritants, your body can rest, so you wake up breathing freely and fully refreshed.”

“Most of us spend more than eight hours a day in our bedrooms, so creating the perfect sleep environment is a great first step for improving our physical and mental health,” remarked Ross. “We’re happy to extend that far beyond the bedroom with the UVFT line of air purifiers that includes our medical-grade RXAir products, that are ideally suited for improving air quality in a wide variety of environments such as offices, healthcare facilities, schools, and industrial facilities.”

Doyle added, “Many industries have been struggling to develop a product that has the natural, hypo-allergenic durability and resilience of our Vytex NRL foam product line. We expect that in the not too distant future it will be used in everything from residential and office furniture to automobiles, boats and theaters and we will all breathe easier and rest more comfortably while benefiting from Vytex foam’s smaller carbon footprint.”

For more information:
www.UVFluTech.com, (877)-FLU-KILL(358-5455) or info@uvflutech.com.
www.vytex.com, (770) 965-0383 or info@vytex.com

About UV Flu Technologies, Inc.

UV Flu Technologies is an innovative developer; manufacturer and distributor of biotechnology products to the rapidly growing $7 billion dollar Indoor Air Quality (“IAQ”) industry. Its ViraTech UV-400 utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOCs (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.). UVFT’s RXAir™ products are certified as FDA Class II medical devices.

About Vystar Corporation

Based in Duluth, GA, Vystar® Corporation (OTCBB: VYST) is the exclusive creator of Vytex Natural Rubber Latex (Vytex NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, balloons, surgical and exam gloves, other medical devices and natural rubber latex foam mattresses and pillows. Vystar’s SleepHealth and Kiron Sleep Lab LLC acquisitions provide an entry into the health and wellness market. For more information, visitwww.vytex.com. www.sleephealthier.com. www.kironsleep.com.

Forward Looking Statement

Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST and UVFT officials are “Forward-Looking Statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as “believes,” “anticipates,” “intends,” “plans,” “expects,” and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Companies to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST and/or UVFT have no specific intention to update these statements.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Public Relations, UV Flu Technologies, UVFT, VYST, Vystar Corp.'s Comments Off Read more...

15 Apr

VCM Development CEO Vaughn Miller to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM

Mr. Miller to Be Interviewed Live Today at 2:45 pm CST / 3:45 pm EST on The Traders Network Radio Show by Host Michael Yorba

DALLAS, TX–(Jan 13, 2014) – VCM Development Group, a leading diversified real estate investment company with a primary focus on retail property development, today announced CEO Vaughn E. Miller will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network.

The interview will air today Monday, January 13, 2014, at 2:45pm U.S. Central Standard Time / 12:45pm Pacific Standard Time / 3:45pm Eastern Standard Time at DFW1190AM.

We encourage all investors, institutional analysts, industry professionals, customers and others who are interested in learning more about recent developments at VCM Development Groupto tune in and listen live via Clear Channel’s iHeart Radio stream. Details below.

Live Interview via iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Date: January 13, 2014
Time: 2:45pm CST | 12:45pm PST | 3:45pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country. DFW1190AM.com Dallas-Ft. Worth. www.clearchannel.com.

About Michael Yorba: Michael Yorba is the featured host of Clear Channel’s DFW 1190AM in Dallas-Ft. Worth, TX. For the past six years he has been integrally involved with the media industry in various capacities including building an IPTV Network, developing, producing and hosting a daily one hour talk show called Commodity Classics, and then later The Traders Network, defined as an audience empowered interactive financial program that has been broadcast live on Internet, television and radio. His focus has been on derivative portfolio analysis for individual and corporate clients through the use of futures and futures options, managed funds, and Forex. www.yorbamedia.com.

About VCM Development Group: Founded in 2013 by Vaughn E. Miller, the oldest surviving son of Dallas real estate legend Vance C. Miller, VCM is a diversified real estate investment company with a primary focus on retail property development. Our portfolio consists of: VCM Development Group LLC, VCM Realty Corporation, Vance C. Miller Holdings Corp, Vance C. Miller Company LLC, Prestonwood Polo Development, LP, Prestonwood Polo Foundation, Inc., Oak Point Retail, Ltd., Oak Point Polo, LLC. Visit our Projects page to learn about our current developments or visit www.vcmdevelopment.com

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Public Relations, Vaughn Miller, VCM Development, VCM Development Group Comments Off Read more...

15 Apr

ChromaDex CEO Frank Jaksch Clear Channel Business Talk Radio Interview ReCap DFW 1190AM

Interview Recap and Archive of Mr. Jaksch’s Live Appearance by Host Michael Yorba

IRVINE, CA–(Jan 10, 2014) – ChromaDex® Corporation (OTCQB: CDXC) (“ChromaDex” or the “Company”), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, is pleased to announced the archive of CEO Frank Jaksch’s recent live interview by Michal Yorba on Clear Channel Business Talk Radio’s “The Traders Network.”

On the heels of ChromaDex’s recently announced $62 million ingredient supply and brand licensing agreement with 5LINX® for Chromadex’s NIAGEN™ nicotinamide riboside and PURENERGY™, CEO and founder Frank Jaksch delivered a captivating interview covering the Company’s unique business model as well as the characteristics that makes its portfolio of patented ingredients compelling to both industry players and investors alike.

In the interview, Jaksch said, “ChromaDex is currently commercialization four patented and proprietary ingredient technologies which address large multibillion dollar markets. NIAGEN™ is our brand for the compound nicotinamide riboside, to be referred to as ‘NR.’ It is closely related to a metabolite of the B vitamin known as Niacin. It is well known for its significant health benefits as well as for being included in many different types of products. There is a common side effect with Niacin — if you take too much you get a flush effect, and it makes people feel pretty uncomfortable. Our version NR is actually a ‘no flush’ version of Niacin that also has more pronounced health benefits largely on increasing NAD+ than Niacin even does. NR is probably the most potent precursor to NAD+, and there has been a lot of activity recently around the importance of NAD+ to energy metabolism, and profound effects that the compound has on aging. NIAGEN™ is a precursor to NAD+ and it has significant effects on improving mitochondrial population. Mitochondria, the energy center of everyone’s cellular processes, are the link to the aging process or age related disease. There was a publication at the end of December by David Sinclair of Harvard Medical School that showed that NAD+, or improving NAD+, can actually reverse the effects of aging, which is one of the first publications that showed something along those lines.”

“Our PURENERGY™ is a caffeine alternative, and everybody is aware of the problems right now in the energy beverage category which is under pressure regarding health concerns for heavily-caffeinated products. We put PURENERGY™ into a human study and we proved that you can deliver more caffeine, more efficiently into the blood then caffeine on its own, which means that you can reduce the amount of caffeine by up to or over 50% without losing the customer expectation — that experience that they want from the caffeine, but with a vastly reduced amount of caffeine.”

Jaksch also highlighted that “ChromaDex is a leader in providing a seamless suite of natural products chemistry and science-based solutions to large, Fortune 500 companies such as Coca Cola, Kraft Foods, Nestle and Abbott Labs.”

To hear the entire Clear Channel Interview with CEO Frank Jaksch, please visit the archive link below:

Interview Archive (12 min, 48 sec)http://www.yorbamedia.com/images/stories/audio/TN010614SEG4.mp3
Network: Clear Channel & iHeart Radio
Station: DFW 1190AM
Host: Michael Yorba

Michael Yorba, Clear Channel host of the Traders Network Show, was quoted saying, “an awesome company doing awesome things!”

About Clear Channel
Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country. DFW1190AM.com Dallas-Ft. Worth, TX www.clearchannel.com

About Michael Yorba
Michael Yorba — featured host of Clear Channels DFW 1190AM in Dallas-Ft.Worth. For the past six years he has been integrally involved with the media industry in various capacities including building an IPTV Network, developing, producing and hosting a daily one hour talk show called Commodity Classics and then later The Traders Network, defined as an audience empowered interactive financial program that has been broadcast live on Internet television and radio. His focus has been on derivative portfolio analysis for individual and corporate clients through the use of futures and futures options, managed funds, and Forex.www.yorbamedia.com.

About ChromaDex®:
ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The company provides seamless science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The ChromaDex ingredient technologies unit includes products backed with extensive scientific research and intellectual property. Its ingredient portfolio includes pTeroPure® pterostilbene; ProC3G™, a natural black rice containing cyanidin-3-glucoside; PURENERGY™, a caffeine-pTeroPure co-crystal; and NIAGEN™, its recently launched branded nicotinamide riboside, a novel next-generation B vitamin. To learn more about ChromaDex, visit www.chromadex.com.

Forward-Looking Statements:
Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

A www.1800PublicRelations.com PR Event

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, 5LINX, ChromaDex, Frank Jaksch, NIAGEN, Public Relations, PURENERGY Comments Off Read more...

15 Apr

Prima BioMed CEO Matthew Lehman to Be Interviewed on Clear Channel Business Talk Radio DFW 1190AM

Mr. Lehman to Be Interviewed Live Today at 2:15 pm CST / 3:15 pm EST on the Traders Network Radio Show by Host Michael Yorba

NEW YORK, NY–(Jan 9, 2014) – Prima BioMed Ltd (ASX: PRR) (NASDAQ:PBMD) (“Prima”, the “Company”), a leader in developing personalized immunocellular therapies for the treatment of cancer, announced today that CEO Matthew Lehman will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network.

The interview will air on Thursday, January 9, 2014, at 2:15pm U.S. Central Standard Time / 12:15pm Pacific Standard Time / 3:15pm Eastern Standard Time.

This corresponds to Friday, January 10th at 7:15am in Sydney, Australia.

Listeners interested in learning more about Prima BioMed’s business and development of CVac™, a product in clinical trials for the treatment of ovarian cancer, can tune in and listen live via Clear Channel’s iHeart Radio stream.

Live Interview via iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Date: January 9, 2014
Time: 2:15pm CST | 12:15pm PST | 3:15pm EST (U.S.)
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country. DFW1190AM.com Dallas-Ft. Worth. www.clearchannel.com.

About Prima BioMed: Prima BioMed is a globally active leader in the development of personalized immunocellular therapeutic products for the treatment of cancer. Prima is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders. Prima’s lead product is CVac™, an autologous dendritic cell-based product currently in clinical trials. www.primabiomed.com.au.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Matthew Lehman, PBMD, Prima BioMed, PRR, Public Relations Comments Off Read more...

(Page 29)